{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-003053","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2025-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.224131+00:00","generated_at":"2026-05-27T22:12:10.965920+00:00","sec_items":["3.01","3.02","3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PAVmed exchanges $22.35M of convertible notes for Series C preferred; targets Nasdaq compliance","bullets":["Exchanged $22,347,543 in principal plus interest of Senior Secured Convertible Notes for 22,347 Series C Preferred shares.","Remaining outstanding principal on Convertible Notes is approximately $6.6 million.","Potential dilution: at voluntary conversion price $1.068/share, ~20.9M common shares; at floor $0.2136, ~104.6M shares.","Company executed exchange to bolster stockholders' equity to meet Nasdaq minimum of $2.5M; compliance deadline Jan 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-003053","json":"https://secwatch.observer/filing/0001493152-25-003053.json","markdown":"https://secwatch.observer/filing/0001493152-25-003053.md","text":"https://secwatch.observer/filing/0001493152-25-003053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225003053/0001493152-25-003053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225003053/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T22:12:10.965920+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}